Cargando…
Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
OBJECTIVE: Epigenetic modifications contribute to the etiology of type 2 diabetes. METHOD: We performed genome-wide methylome and transcriptome analysis in liver from severely obese men with or without type 2 diabetes and non-obese men to discover aberrant pathways underlying the development of insu...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770265/ https://www.ncbi.nlm.nih.gov/pubmed/26977391 http://dx.doi.org/10.1016/j.molmet.2015.12.004 |
_version_ | 1782418231048273920 |
---|---|
author | Kirchner, Henriette Sinha, Indranil Gao, Hui Ruby, Maxwell A. Schönke, Milena Lindvall, Jessica M. Barrès, Romain Krook, Anna Näslund, Erik Dahlman-Wright, Karin Zierath, Juleen R. |
author_facet | Kirchner, Henriette Sinha, Indranil Gao, Hui Ruby, Maxwell A. Schönke, Milena Lindvall, Jessica M. Barrès, Romain Krook, Anna Näslund, Erik Dahlman-Wright, Karin Zierath, Juleen R. |
author_sort | Kirchner, Henriette |
collection | PubMed |
description | OBJECTIVE: Epigenetic modifications contribute to the etiology of type 2 diabetes. METHOD: We performed genome-wide methylome and transcriptome analysis in liver from severely obese men with or without type 2 diabetes and non-obese men to discover aberrant pathways underlying the development of insulin resistance. Results were validated by pyrosequencing. RESULT: We identified hypomethylation of genes involved in hepatic glycolysis and insulin resistance, concomitant with increased mRNA expression and protein levels. Pyrosequencing revealed the CpG-site within ATF-motifs was hypomethylated in four of these genes in liver of severely obese non-diabetic and type 2 diabetic patients, suggesting epigenetic regulation of transcription by altered ATF-DNA binding. CONCLUSION: Severely obese non-diabetic and type 2 diabetic patients have distinct alterations in the hepatic methylome and transcriptome, with hypomethylation of several genes controlling glucose metabolism within the ATF-motif regulatory site. Obesity appears to shift the epigenetic program of the liver towards increased glycolysis and lipogenesis, which may exacerbate the development of insulin resistance. |
format | Online Article Text |
id | pubmed-4770265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-47702652016-03-14 Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients Kirchner, Henriette Sinha, Indranil Gao, Hui Ruby, Maxwell A. Schönke, Milena Lindvall, Jessica M. Barrès, Romain Krook, Anna Näslund, Erik Dahlman-Wright, Karin Zierath, Juleen R. Mol Metab Original Article OBJECTIVE: Epigenetic modifications contribute to the etiology of type 2 diabetes. METHOD: We performed genome-wide methylome and transcriptome analysis in liver from severely obese men with or without type 2 diabetes and non-obese men to discover aberrant pathways underlying the development of insulin resistance. Results were validated by pyrosequencing. RESULT: We identified hypomethylation of genes involved in hepatic glycolysis and insulin resistance, concomitant with increased mRNA expression and protein levels. Pyrosequencing revealed the CpG-site within ATF-motifs was hypomethylated in four of these genes in liver of severely obese non-diabetic and type 2 diabetic patients, suggesting epigenetic regulation of transcription by altered ATF-DNA binding. CONCLUSION: Severely obese non-diabetic and type 2 diabetic patients have distinct alterations in the hepatic methylome and transcriptome, with hypomethylation of several genes controlling glucose metabolism within the ATF-motif regulatory site. Obesity appears to shift the epigenetic program of the liver towards increased glycolysis and lipogenesis, which may exacerbate the development of insulin resistance. Elsevier 2016-01-02 /pmc/articles/PMC4770265/ /pubmed/26977391 http://dx.doi.org/10.1016/j.molmet.2015.12.004 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Kirchner, Henriette Sinha, Indranil Gao, Hui Ruby, Maxwell A. Schönke, Milena Lindvall, Jessica M. Barrès, Romain Krook, Anna Näslund, Erik Dahlman-Wright, Karin Zierath, Juleen R. Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients |
title | Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients |
title_full | Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients |
title_fullStr | Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients |
title_full_unstemmed | Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients |
title_short | Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients |
title_sort | altered dna methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770265/ https://www.ncbi.nlm.nih.gov/pubmed/26977391 http://dx.doi.org/10.1016/j.molmet.2015.12.004 |
work_keys_str_mv | AT kirchnerhenriette altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT sinhaindranil altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT gaohui altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT rubymaxwella altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT schonkemilena altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT lindvalljessicam altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT barresromain altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT krookanna altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT naslunderik altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT dahlmanwrightkarin altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients AT zierathjuleenr altereddnamethylationofglycolyticandlipogenicgenesinliverfromobeseandtype2diabeticpatients |